Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration
暂无分享,去创建一个
U. Gärtner | T. Arendt | U. Gärtner | M. Holzer | T. Arendt | M. Holzer
[1] A. Smith,et al. Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions , 1997, Acta Neuropathologica.
[2] P. Gluckman,et al. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. , 1997, Brain research. Molecular brain research.
[3] A. Smith,et al. The cell division cycle and the pathophysiology of Alzheimer's disease. , 1998, Neuroscience.
[4] A. Smith,et al. Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.
[5] E. Sadot,et al. Ras‐Signaling Pathways: Positive and Negative Regulation of Tau Expression in PC12 Cells , 1998, Journal of neurochemistry.
[6] T. Arendt,et al. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.
[7] S. Scott,et al. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. , 1996, Brain research. Molecular brain research.
[8] T. Arendt,et al. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease , 1998, Journal of Neural Transmission.
[9] G. Jicha,et al. Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.
[10] V. Ingram,et al. Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease. , 1994, Biochemical and biophysical research communications.
[11] M. Viitanen,et al. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[12] U. Gärtner,et al. Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.
[13] P. Greengard,et al. Regulation of Secretion of Alzheimer Amyloid Precursor Protein by the Mitogen‐Activated Protein Kinase Cascade , 1998, Journal of neurochemistry.
[14] M. Ewen,et al. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.
[15] J. Rubin,et al. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease , 1998, Brain Research.
[16] E. Mandelkow,et al. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. , 1998, Molecular biology of the cell.
[17] L. Phillips,et al. Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrus , 1994, Neuroscience.
[18] K. Herrup,et al. Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain , 1998, The Journal of Neuroscience.
[19] H. Yeh,et al. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] T. Arendt,et al. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease , 1995, The Journal of comparative neurology.
[21] Á. Pascual,et al. Nerve Growth Factor and Ras Regulate β‐Amyloid Precursor Protein Gene Expression in PC12 Cells , 1996, Journal of neurochemistry.
[22] Y. Agid,et al. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. , 1985, Brain : a journal of neurology.
[23] D. Selkoe,et al. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Lowy,et al. Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. , 1984, The EMBO journal.
[25] Brian J Cummings,et al. Induction of basic fibroblast growth factor in Alzheimer's disease pathology. , 1990, Neuroreport.
[26] P. Reiner,et al. Regulation of Amyloid Precursor Protein Catabolism Involves the Mitogen-Activated Protein Kinase Signal Transduction Pathway , 1997, The Journal of Neuroscience.
[27] C. Marshall,et al. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein , 1997, Current Biology.
[28] P. Davies,et al. Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.
[29] T. Arendt,et al. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease , 1995, Neuroscience.
[30] S. Green,et al. ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells , 1991, The Journal of cell biology.
[31] G. Drewes,et al. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.
[32] R. Heumann,et al. Induction of p21ras in Alzheimer pathology. , 1995, Neuroreport.